ASX:OSL OncoSil Medical (OSL) Stock Price, News & Analysis → The World’s Richest Man Blindsided by AI (From Banyan Hill Publishing) (Ad) Free OSL Stock Alerts Add Compare Share Share Today's Range N/A50-Day Range N/A52-Week Range N/AVolume2.17 million shsAverage VolumeN/AMarket CapitalizationN/AP/E RatioN/ADividend YieldN/APrice TargetN/A Stock AnalysisStock Analysis Get OncoSil Medical alerts: Email Address Ad InvestorPlaceCrypto Millionaire Says: “Buy This $11 AI Coin.”Right now, you can harness the power of two bull markets... Artificial intelligence...And cryptos.Find out more about this $11 AI Coin right now About OncoSil MedicalOncoSil Medical Limited, a medical device company, focuses on the development and commercialization of localized radiation therapy for the treatment of pancreatic and distal cholangiocarcinoma in worldwide. Its lead product is OncoSil, a brachytherapy device indicated for the treatment of patients with locally advanced pancreatic cancer in combination with gemcitabine-based chemotherapy. OncoSil Medical Limited was incorporated in 2005 and is headquartered in Macquarie Park, Australia.Read More Ad InvestorPlaceCrypto Millionaire Says: “Buy This $11 AI Coin.”Right now, you can harness the power of two bull markets... Artificial intelligence...And cryptos.Find out more about this $11 AI Coin right now OSL Stock News HeadlinesMay 6, 2024 | finance.yahoo.comOncoSil Medical's Market Cap Drops To AU$12m Leaving Insiders With LossesMay 2, 2024 | msn.comTop 10 at 10: ‘Outstanding’ lithium hits and a $30m ADF cash splashMay 1, 2024 | msn.comMarket Highlights: Wall Street in a sea of red, and cannabis stocks in focus after US reportDecember 9, 2023 | morningstar.comOncoSil Medical Ltd OSLNovember 22, 2023 | finance.yahoo.comShareholders May Not Be So Generous With OncoSil Medical Limited's (ASX:OSL) CEO Compensation And Here's WhySeptember 1, 2023 | finance.yahoo.comOncoSil Medical Full Year 2023 Earnings: AU$0.01 loss per share (vs AU$0.013 loss in FY 2022)May 20, 2023 | uk.news.yahoo.comSarah Cameron Bought 738% More Shares In OncoSil MedicalMay 20, 2023 | finance.yahoo.comSarah Cameron Bought 738% More Shares In OncoSil Medical \March 1, 2023 | finance.yahoo.comAnalysts Expect Breakeven For OncoSil Medical Limited (ASX:OSL) Before LongOctober 10, 2022 | fool.com.auHow FDA approval takes Oncosil Medical Ltd closer to the Holy GrailSeptember 9, 2022 | reuters.comOncosil Medical LtdAugust 11, 2022 | finance.yahoo.comWe're A Little Worried About OncoSil Medical's (ASX:OSL) Cash Burn RateApril 13, 2022 | msn.comTop 10 at 10: The ASX stocks blowing your socks off in early tradeApril 13, 2022 | fool.com.auThe OncoSil Medical share price is booming 66%. Here’s whyJanuary 7, 2022 | afr.comOncosil Medical LimitedDecember 23, 2021 | msn.comWhy is the OncoSil Medical (ASX:OSL) share price surging 18% today?September 6, 2021 | finance.yahoo.comHere's Why We're Watching OncoSil Medical's (ASX:OSL) Cash Burn SituationSee More Headlines Receive OSL Stock News and Ratings via Email Sign-up to receive the latest news and ratings for OncoSil Medical and its competitors with MarketBeat's FREE daily newsletter. Email Address Industry, Sector and Symbol Stock ExchangeASX SectorMedical Industry Medical Devices Sub-IndustryN/A Current SymbolASX:OSL CUSIPN/A CIKN/A Webwww.oncosil.com.au Phone61 2 9223 3344FaxN/AEmployeesN/AYear FoundedN/AProfitability EPS (Most Recent Fiscal Year)A($0.01) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income$-11,710,000.00 Net MarginsN/A Pretax MarginN/A Return on Equity-237.87% Return on Assets-103.64% Debt Debt-to-Equity Ratio2.62 Current Ratio2.74 Quick Ratio6.89 Sales & Book Value Annual Sales$1.30 million Price / Sales0.00 Cash FlowN/A Price / Cash Flow10.91 Book ValueN/A Price / BookN/AMiscellaneous Outstanding Shares3,080,000,000Free FloatN/AMarket CapN/A OptionableNot Optionable Beta0.34 10 Best Cheap Stocks to Buy NowMarketBeat just released its list of 10 cheap stocks that have been overlooked by the market and may be seriously undervalued. Click the link below to see which companies made the list.Get This Free Report Key ExecutivesMr. Nigel LangeCEO, MD & DirectorMr. Christian Dal CinCFO & Company SecretaryDr. Ralph PetersChief Medical OfficerMr. David TurnerHead of Medical AffairsKey Competitors4DMedicalASX:4DXAdheriumASX:ADRAinosNASDAQ:AIMDWAllegra Medical TechnologiesASX:AMTAnalyticaASX:ALTView All CompetitorsInsidersNigel LangeSold 91,500,000 sharesTotal: $366,000.00 ($0.00/share)Otto ButtulaSold 5,307,693 sharesTotal: $63,692.32 ($0.01/share) OSL Stock Analysis - Frequently Asked Questions What other stocks do shareholders of OncoSil Medical own? Based on aggregate information from My MarketBeat watchlists, some companies that other OncoSil Medical investors own include Champion Iron (CIA), Blackmores (BKL), APA Group (APA), WiseTech Global (WTC), Twitter (TWTR), Qube (QUB), Procter & Gamble (PG) and Charter Hall Social Infrastructure REIT (CQE). This page (ASX:OSL) was last updated on 5/14/2024 by MarketBeat.com Staff From Our PartnersRed Alert: Your Money's Disappearance Act - Banks' Greed Unleashed!Priority GoldHealthcare Takes A Big Step Forward With The Help Of AIThe Bull ReportRevolutionizing the Green Energy Space and Building Shareholder Value Along the WaySmall Cap SniperInvest Now: Starpax's Cancer Breakthrough Achieving What Others Haven't for a CenturyStarpaxHUGE BUY ALERT: Move Fast, Musk...Stansberry ResearchDemocrats Push to Replace Dollar With Digital Coin, Control Currency.Monetary GoldTrump’s “Tax Free” Retirement Strategy Gold Safe ExchangeConflict In Israel Sends Gold Soaring ???? Here’s How To Get Your ShareColonial Metals Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding OncoSil Medical Limited Please log in to your account or sign up in order to add this asset to your watchlist. Get 30 Days of MarketBeat All Access Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools: Best-in-Class Portfolio Monitoring View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio. Stock Ideas and Recommendations Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report. Advanced Stock Screeners and Research Tools Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis. Start Your 30-Day Free Trial Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
